IP Library Granted Patent US 10,172,878
Granted Patent B2
US 10,172,878 · App. 15/357,597 · Granted Jan 8, 2019

Extended-release topiramate capsules

Inventors: Sarah Michelle Betterman (Champlin, MN); Jaidev Srinivas Tantry (Maple Grove, MN); Laura Marie Patrick (Eden Prairie, MN)
Assignee: UPSHER-SMITH LABORATORIES, LLC
A61K31/7048A61K9/4808A61K9/5042A61K9/5047A61K31/357
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,172,878
App. No.
15/357,597
Granted
Jan 8, 2019
Kind
B2
Abstract

An extended-release topiramate capsule that includes a capsule shell containing a single population of coated particles; wherein each coated particle includes a core and a coating thereon; wherein each particle core includes a homogeneous mixture comprising topiramate throughout its core; and wherein the coating includes one or more release controlling agent(s).

Claims (58)

1. A container comprising an extended-release topiramate capsule and desiccant, wherein the extended-release topiramate capsule comprises:

a capsule shell comprising a single population of coated particles;

wherein each coated particle comprises a core and a coating thereon;

wherein each particle core comprises a homogeneous mixture throughout its core, the mixture comprising:

topiramate;

one or more filler(s); and

one or more binder(s);

wherein the coating comprises:

one or more release controlling agent(s);

one or more pore former(s); and

one or more plasticizer(s);

wherein the components in the particle core and coating are present in amounts that provide extended release of topiramate; and

wherein, when a single dose is given to a healthy human subject, an AUC 0-inf of 170 to 210 h·μg/mL within a 95% confidence interval, and a C max of 2 to 4 μg/mL within a 95% confidence interval are achieved in the subject's plasma.

2. The container of claim 1 wherein the ratio of weight of desiccant to weight of filled capsules is at least 0.01.

3. The container of claim 1 wherein the ratio of weight of desiccant to weight of filled capsules is up to 0.9.

4. The container of claim 1 wherein the desiccant is selected from silica gel, bentonite clay, molecular sieve, and combinations thereof.

5. A container comprising an extended-release topiramate capsule and desiccant, wherein the extended-release topiramate capsule comprises:

a capsule shell comprising a single population of coated particles;

wherein each coated particle comprises a core and a coating thereon;

wherein each particle core comprises a homogeneous mixture throughout its core, the mixture comprising:

40 wt-% to 50 wt-% of topiramate, based on the total weight of an uncoated particle core;

45 wt-% to 55 wt-% of one or more filler(s), based on the total weight of an uncoated particle core; and

3 wt-% to 7 wt-% of one or more binder(s), based on the total weight of an uncoated particle core;

wherein the coating comprises:

55 wt-% to 65 wt-% of one or more release control agent(s), based on the total weight of the coating;

20 wt-% to 25 wt-% of one or more pore former(s), based on the total weight of the coating; and

10 wt-% to 20 wt-% of one or more plasticizer(s), based on the total weight of the coating;

wherein the particles are coated in an amount sufficient to provide a weight gain of 8% to 14%.

6. The container of claim 5 wherein each particle core comprises a homogeneous mixture throughout its core, the mixture comprising:

40 wt-% to 50 wt-% of topiramate, based on the total weight of an uncoated particle core;

45 wt-% to 55 wt-% of one or more filler(s), based on the total weight of an uncoated particle core; wherein the one or more filler(s) is selected from the group of microcrystalline cellulose, dibasic calcium phosphate, lactose, tribasic calcium phosphate, mannitol, and combinations thereof; and

3 wt-% to 7 wt-% of one or more binder(s), based on the total weight of an uncoated particle core; wherein the one or more binder(s) is selected from the group of hydroxypropyl methylcellulose, methylcellulose, carboxymethylcellulose, sodium carboxymethylcellulose, hydroxypropyl cellulose, hydroxyethylcellulose, polyvinyl pyrrolidine, starch, natural gum, and combinations thereof;

wherein the coating comprises:

55 wt-% to 65 wt-% of one or more release control agent(s), based on the total weight of the coating; wherein the one or more release controlling agent(s) is selected from the group of ethylcellulose, polyvinyl acetate, polyacrylate and polymethacrylate, copolymers thereof, and combinations thereof;

20 wt-% to 25 wt-% of one or more pore former(s), based on the total weight of the coating; wherein the one or more pore former(s) is selected from the group of hypromellose, hydroxypropyl cellulose, methylcellulose, hydroxyethylcellulose, carboxymethylcellulose, sodium carboxymethylcellulose, polyethylene glycol, guar gum, xanthan gum, sodium alginate, polyvinylpyrrolidone, crospovidone, sodium starch glycolate, croscarmellose sodium, starch, mannitol, glucose, sucrose, fructose, mannose, galactose, sorbitol, dextran, sodium chloride, potassium chloride, calcium chloride, and combinations thereof; and

10 wt-% to 20 wt-% of one or more plasticizer(s), based on the total weight of the coating; wherein the one or more plasticizer(s) is selected from the group of diethyl phthalate, triethyl citrate, dibutyl sebacate, polyethylene glycol, triacetin, tributyl citrate, glycerol, propylene glycol, and combinations thereof;

wherein the particles are coated in an amount sufficient to provide a weight gain of 8% to 14%.

7. The container of claim 6 wherein each particle core comprises a homogeneous mixture throughout its core, the mixture comprising:

40-50 wt-% of topiramate, based on the total weight of an uncoated particle core;

45-55 wt-% of microcrystalline cellulose, based on the total weight of an uncoated particle core; and

3-7 wt-% of hydroxypropyl methylcellulose, based on the total weight of an uncoated particle core;

wherein the coating comprises:

55-65 wt-% of ethylcellulose, based on the total weight of the coating;

20-25 wt-% of hydroxypropyl methylcellulose, based on the total weight of the coating; and

10-20 wt-% of diethyl phthalate, based on the total weight of the coating;

wherein the particles are coated in an amount sufficient to provide a weight gain of 8% to 14%.

8. The container of claim 7 wherein each particle core comprises a homogeneous mixture throughout its core, the mixture comprising:

44-46 wt-% of topiramate, based on the total weight of an uncoated particle core;

48-52 wt-% of microcrystalline cellulose, based on the total weight of an uncoated particle core; and

4-6 wt-% of hydroxypropyl methylcellulose, based on the total weight of an uncoated particle core;

wherein the coating comprises:

60-62 wt-% of ethylcellulose, based on the total weight of the coating;

22-24 wt-% of hydroxypropyl methylcellulose, based on the total weight of the coating; and

15-18 wt-% of diethyl phthalate, based on the total weight of the coating;

wherein the particles are coated in an amount sufficient to provide a weight gain of 10-12%.

9. The container of claim 5 wherein the ratio of weight of desiccant to weight of filled capsules is at least 0.01.

10. The container of claim 5 wherein the ratio of weight of desiccant to weight of filled capsules is up to 0.9.

11. The container of claim 5 wherein the desiccant is selected from silica gel, bentonite clay, molecular sieve, and combinations thereof.

Assignments (2)
CHANGE OF NAME Recorded Jun 12, 2017
From: UPSHER-SMITH LABORATORIES, INC.
To: UPSHER-SMITH LABORATORIES, LLC
Reel/Frame 042765/0909 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 15, 2016
From: BETTERMAN, SARAH MICHELLE; TANTRY, JAIDEV SRINIVAS; PATRICK, LAURA MARIE
To: UPSHER-SMITH LABORATORIES, INC.
Reel/Frame 040739/0800 →
Continuity (5)
Continuation 14731444 · Jun 5, 2015
Continuation 14212121 · Mar 14, 2014
Continuation 14157646 · Jan 17, 2014
Continuation 13847042 · Mar 19, 2013
Related Publication 20170119808A1 · May 4, 2017